A. Brind, A. Fryer, A. Hurlstone, N. Fisher, and M. Pirmohamed, The role of polymorphism in manganese superoxide dismutase in susceptibility to alcoholic liver disease, Gastroenterology, vol.124, issue.7, pp.2000-2002, 2003.
DOI : 10.1016/S0016-5085(03)00574-2

M. Brouwer, A. Van-der-ende, F. Baas, and D. Van-de-beek, Genetic variation in GLCCI1 and dexamethasone in bacterial meningitis, Journal of Infection, vol.65, issue.5, pp.465-472, 2012.
DOI : 10.1016/j.jinf.2012.07.001

J. Browning, J. Cohen, and H. Hobbs, Patatin-like phospholipase domain-containing 3, 2010.

A. Chamorro, J. Torres, J. Mirón-canelo, R. González-sarmiento, F. Laso et al., ) is significantly associated with alcoholic liver cirrhosis, Alimentary Pharmacology & Therapeutics, vol.107, issue.6, pp.571-579, 2014.
DOI : 10.1073/pnas.1003585107

H. Cheong, H. Kang, and J. Schlondorff, GLCCI1 single nucleotide polymorphisms in pediatric nephrotic syndrome, Pediatric Nephrology, vol.108, issue.9, pp.1595-1604, 2012.
DOI : 10.1016/0303-7207(95)03481-L

C. Child and J. Turcotte, Surgery and portal hypertension In: The liver and portal hypertension. Saunders, pp.50-64, 1964.

A. Colell, C. García-ruiz, M. Miranda, E. Ardite, M. Marí et al., Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor, Gastroenterology, vol.115, issue.6, pp.1541-51, 1998.
DOI : 10.1016/S0016-5085(98)70034-4

F. Degoul, A. Sutton, A. Mansouri, C. Cepanec, C. Degott et al., Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease, Gastroenterology, vol.120, issue.6, pp.1468-1474, 2001.
DOI : 10.1053/gast.2001.24051

E. Falleti, C. Fabris, S. Cmet, A. Cussigh, D. Bitetto et al., PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence, Liver International, vol.40, issue.(Suppl. 1), pp.1137-1180, 2011.
DOI : 10.1111/j.1872-034X.2010.00692.x

J. Fernández-checa, C. García-ruiz, M. Ookhtens, and N. Kaplowitz, Impaired uptake of glutathione by hepatic mitochondria from chronic ethanol-fed rats. Tracer kinetic studies in vitro and in vivo and susceptibility to oxidant stress., Journal of Clinical Investigation, vol.87, issue.2, pp.397-405, 1991.
DOI : 10.1172/JCI115010

B. Gao and R. Bataller, Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets, Gastroenterology, vol.141, issue.5, pp.1572-85, 2011.
DOI : 10.1053/j.gastro.2011.09.002

J. Grove, A. Daly, M. Bassendine, E. Gilvarry, and C. Day, Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease, Gut, vol.46, issue.4, pp.540-545, 2000.
DOI : 10.1136/gut.46.4.540

URL : http://gut.bmj.com/content/gutjnl/46/4/540.full.pdf

S. Guérin, A. Laplanche, A. Dunant, and C. Hill, Alcohol-attributable mortality in France Eur J Public Health, pp.588-93, 2013.

S. He, C. Mcphaul, J. Li, R. Garuti, L. Kinch et al., A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis, Journal of Biological Chemistry, vol.266, issue.9, pp.6706-6715, 2010.
DOI : 10.1016/j.cmet.2006.03.005

L. Hosking, E. Bleecker, S. Ghosh, A. Yeo, L. Jacques et al., GLCCI1 rs37973 does not influence treatment response to inhaled corticosteroids in white subjects with asthma, Journal of Allergy and Clinical Immunology, vol.133, issue.2, pp.587-596, 2014.
DOI : 10.1016/j.jaci.2013.08.024

Y. Huang, S. He, J. Li, Y. Seo, T. Osborne et al., A feed-forward loop amplifies nutritional regulation of PNPLA3, Proceedings of the National Academy of Sciences, vol.107, issue.17, pp.7892-7899, 2010.
DOI : 10.1074/jbc.274.42.30028

Y. Huang, C. Chang, T. Lin, and C. Perng, Genetic variations of superoxide dismutase 2 and cytochrome P450 2E1 in non-alcoholic steatohepatitis, Liver International, vol.5, issue.6, pp.931-937, 2014.
DOI : 10.1097/00008571-199510000-00005

Z. Hrubec and G. Omenn, Evidence of Genetic Predisposition to Alcoholic Cirrhosis and Psychosis: Twin Concordances for Alcoholism and Its Biological End Points by Zygosity among Male Veterans, Alcoholism: Clinical and Experimental Research, vol.28, issue.2, pp.207-222, 1981.
DOI : 10.1111/j.1469-1809.1965.tb00500.x

F. Jin, W. Xiong, J. Jing, Z. Feng, L. Qu et al., Evaluation of the association studies of single nucleotide polymorphisms and hepatocellular carcinoma: a systematic review, Journal of Cancer Research and Clinical Oncology, vol.28, issue.2, pp.1095-104, 2011.
DOI : 10.1002/gepi.20048

P. Kamath, R. Wiesner, M. Malinchoc, W. Kremers, T. Therneau et al., A model to predict survival in patients with end-stage liver disease, Hepatology, vol.33, issue.2, pp.464-70, 2001.
DOI : 10.1053/jhep.2001.22172

A. Khan, G. Choudhuri, Q. Husain, and D. Parmar, Polymorphism in glutathione-S-transferases: A risk factor in alcoholic liver cirrhosis, Drug and Alcohol Dependence, vol.101, issue.3, pp.183-90, 2009.
DOI : 10.1016/j.drugalcdep.2008.12.001

B. Kollerits, S. Coassin, S. Kiechl, S. Hunt, B. Paulweber et al., A common variant in the adiponutrin gene influences liver enzyme values, Journal of Medical Genetics, vol.47, issue.2, pp.116-125, 2010.
DOI : 10.1136/jmg.2009.066597

M. Krawczyk, F. Grünhage, V. Zimmer, and F. Lammert, Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: Non-invasive elastography-based study in chronic liver disease, Journal of Hepatology, vol.55, issue.2, pp.299-306, 2011.
DOI : 10.1016/j.jhep.2010.10.042

J. Ladero, C. Martínez, E. García-martin, M. Fernández-arquero, G. López-alonso et al., Polymorphisms of the glutathione S-transferases mu-1 (GSTM1) and theta-1 (GSTT1) and the risk of advanced alcoholic liver disease, Scandinavian Journal of Gastroenterology, vol.120, issue.1, pp.348-53, 2005.
DOI : 10.1002/ajmg.a.20010

C. S. Lieber, Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis, Alcohol, vol.34, issue.1, pp.9-19, 2004.
DOI : 10.1016/j.alcohol.2004.07.008

M. Lucey, P. Mathurin, and T. Morgan, Alcoholic Hepatitis, New England Journal of Medicine, vol.360, issue.26, pp.2758-69, 2009.
DOI : 10.1056/NEJMra0805786

M. Marcos, I. Pastor, R. González-sarmiento, and F. Laso, Common polymorphisms in interleukin genes (IL4, IL6, IL8 and IL12) are not associated with alcoholic liver disease or alcoholism in Spanish men, Cytokine, vol.45, issue.3, pp.158-61, 2009.
DOI : 10.1016/j.cyto.2008.11.003

P. Mathurin, C. Mendenhall, R. Carithers, . Jr, M. Ramond et al., Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH, Journal of Hepatology, vol.36, issue.4, pp.480-487, 2002.
DOI : 10.1016/S0168-8278(01)00289-6

P. Mathurin, O. Grady, J. Carithers, R. Phillips, M. Louvet et al., Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data, Gut, vol.60, issue.2, pp.255-60, 2011.
DOI : 10.1136/gut.2010.224097

A. Miller, N. Horiguchi, W. Jeong, S. Radaeva, and B. Gao, Molecular Mechanisms of Alcoholic Liver Disease: Innate Immunity and Cytokines, Alcoholism: Clinical and Experimental Research, vol.181, issue.5, pp.787-93, 2011.
DOI : 10.4049/jimmunol.181.5.3049

P. Nahon, A. Sutton, D. Pessayre, P. Rufat, F. Degoul et al., Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death, Clinical Gastroenterology and Hepatology, vol.3, issue.3, pp.292-300, 2005.
DOI : 10.1016/S1542-3565(04)00718-9

S. Naveau, V. Giraud, E. Borotto, A. A. Capron, F. Chaput et al., Excess weight risk factor for alcoholic liver disease, Hepatology, vol.25, issue.1, pp.108-119, 1997.
DOI : 10.1002/hep.510250120

E. Nguyen-khac, H. Houchi, M. Daoust, J. Dupas, and M. Naassila, The ???308 TNF?? Gene Polymorphism in Severe Acute Alcoholic Hepatitis: Identification of a New Susceptibility Marker, Alcoholism: Clinical and Experimental Research, vol.107, issue.5, pp.822-830, 2008.
DOI : 10.1002/hep.21023

E. Nguyen-khac, H. Houchi, M. Daoust, J. Dupas, and M. Naassila, Lack of association between tumour necrosis factor receptor types 1 and 2 gene polymorphism and severe acute alcoholic hepatitis, European Journal of Gastroenterology & Hepatology, vol.22, issue.7, pp.794-800, 2010.
DOI : 10.1097/MEG.0b013e32832f5bba

URL : https://hal.archives-ouvertes.fr/inserm-00746165

S. Thoraval and S. Naveau, Severe acute alcoholic hepatitis in France (AAH) in 2008: a nationwide survey results (AFEF, ANGH, SNFMI), J Hepatol, vol.52, p.445, 2010.

E. Nguyen-khac, T. Thevenot, M. Piquet, S. Benferhat, O. Goria et al., Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis, AAH-NAC Study Group. N Engl J Med, vol.10365, pp.1781-1790, 2011.
DOI : 10.1056/nejmoa1101214

F. Paille and M. Reynaud, L'alcool, une des toutes premières causes d'hospitalisation en France, BEH -Bulletin Epidémiologique Hebdomadaire, pp.440-449, 2015.

C. Perera, S. Clair, D. Mcclain, and C. , Differential Regulation of Manganese Superoxide Dismutase Activity by Alcohol and TNF in Human Hepatoma Cells, Archives of Biochemistry and Biophysics, vol.323, issue.2, pp.471-477, 1995.
DOI : 10.1006/abbi.1995.0069

D. Pessayre, B. Fromenty, and A. Mansouri, Mitochondrial injury in steatohepatitis, European Journal of Gastroenterology & Hepatology, vol.16, issue.11, pp.1095-105, 2004.
DOI : 10.1097/00042737-200411000-00003

P. Pingitore, C. Pirazzi, R. Mancina, B. Motta, C. Indiveri et al., Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1841, issue.4, pp.1388-198100279, 2013.
DOI : 10.1016/j.bbalip.2013.12.006

R. Pugh, I. Murray-lyon, J. Dawson, M. Pietroni, and R. Williams, Transection of the oesophagus for bleeding oesophageal varices. The British journal of surgery, pp.646-655, 1973.

R. Quax, L. Manenschijn, J. Koper, J. Hazes, S. Lamberts et al., Glucocorticoid sensitivity in health and disease, Nature Reviews Endocrinology, vol.14, issue.11, pp.670-86, 2013.
DOI : 10.1186/ar4029

R. Rao, Endotoxemia and gut barrier dysfunction in alcoholic liver disease, Hepatology, vol.35, issue.suppl 1, pp.638-682, 2009.
DOI : 10.1093/alcalc/35.6.561

URL : http://onlinelibrary.wiley.com/doi/10.1002/hep.23009/pdf

S. Romeo, J. Kozlitina, C. Xing, A. Pertsemlidis, D. Cox et al., Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease, Nature Genetics, vol.164, issue.12, pp.1461-1466, 2008.
DOI : 10.1038/ng1984

S. Romeo, F. Sentinelli, V. Cambuli, M. Incani, T. Congiu et al., The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life, Journal of Hepatology, vol.53, issue.2, pp.335-343, 2010.
DOI : 10.1016/j.jhep.2010.02.034

Y. Rotman, C. Koh, J. Zmuda, D. Kleiner, and T. Liang, The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease, Hepatology, vol.29, issue.3, pp.894-903, 2010.
DOI : 10.1530/EJE-08-0426

C. Roumestan, C. Gougat, D. Jaffuel, and M. Mathieu, Les glucocortico??des et leur r??cepteur??: m??canismes d'action et cons??quences cliniques, La Revue de M??decine Interne, vol.25, issue.9, pp.636-683, 2004.
DOI : 10.1016/j.revmed.2004.01.012

S. Sookoian and C. Pirola, Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease, Hepatology, vol.25, issue.6, pp.1883-94, 2011.
DOI : 10.1111/j.1365-2036.2007.03246.x

W. Srikureja, N. Kyulo, B. Runyon, and K. Hu, MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis, Journal of Hepatology, vol.42, issue.5, pp.700-706, 2005.
DOI : 10.1016/j.jhep.2004.12.022

S. Stewart, J. Leathart, Y. Chen, A. Daly, R. Rolla et al., Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis, Hepatology, vol.17, issue.6, pp.1355-60, 2002.
DOI : 10.1002/hep.1840360610

J. Hampe, Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians, Hepatology, vol.53, pp.86-95, 2011.

A. Sutton, H. Khoury, C. Prip-buus, C. Cepanec, D. Pessayre et al., The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria, Pharmacogenetics, vol.13, issue.3, pp.145-57, 2003.
DOI : 10.1097/00008571-200303000-00004

R. Szalai, P. Matyas, D. Varszegi, M. Melegh, L. Magyari et al., Admixture of beneficial and unfavourable variants of GLCCI1 and FCER2 in Roma samples can implicate different clinical response to corticosteroids, Molecular Biology Reports, vol.20, issue.5, pp.417665-417674, 2014.
DOI : 10.1093/eurpub/ckq102

K. Tantisira, J. Lasky-su, M. Harada, A. Murphy, A. Litonjua et al., and Response to Glucocorticoid Therapy in Asthma, New England Journal of Medicine, vol.365, issue.13, pp.1173-83, 2011.
DOI : 10.1056/NEJMoa0911353

E. Trépo, T. Gustot, D. Degré, A. Lemmers, L. Verset et al., Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease, Journal of Hepatology, vol.55, issue.4, pp.906-918, 2011.
DOI : 10.1016/j.jhep.2011.01.028

S. Vijverberg, R. Tavendale, M. Leusink, L. Koenderman, J. Raaijmakers et al., in three north European pediatric asthma populations with a reported use of inhaled corticosteroids, Pharmacogenomics, vol.7, issue.6, pp.799-806, 2014.
DOI : 10.2217/pgs.13.195

Y. Li and A. Diehl, Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis, Hepatology, vol.45, pp.1366-1374, 2007.